Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genome-wide association study identifies 16 genomic regions associated with circulating cytokines at birth

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A novel homozygous GFI1B variant in 2 sisters with thrombocytopenia and severe bleeding tendency

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Need for Hospitalization due to SARS-CoV-2 in Children: A Population-based Estimate

    Publikation: Bidrag til tidsskriftLetterpeer review

  3. Direct to consumer genetic testing in Denmark-public knowledge, use, and attitudes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

PURPOSE: Historically, cancer predisposition syndromes (CPSs) were rarely established for children with cancer. This nationwide, population-based study investigated how frequently children with cancer had or were likely to have a CPS.

METHODS: Children (0-17 years) in Denmark with newly diagnosed cancer were invited to participate in whole-genome sequencing of germline DNA. Suspicion of CPS was assessed according to Jongmans'/McGill Interactive Pediatric OncoGenetic Guidelines (MIPOGG) criteria and familial cancer diagnoses were verified using population-based registries.

RESULTS: 198 of 235 (84.3%) eligible patients participated, of whom 94/198 (47.5%) carried pathogenic variants (PVs) in a CPS gene or had clinical features indicating CPS. Twenty-nine of 198 (14.6%) patients harbored a CPS, of whom 21/198 (10.6%) harbored a childhood-onset and 9/198 (4.5%) an adult-onset CPS. In addition, 23/198 (11.6%) patients carried a PV associated with biallelic CPS. Seven of the 54 (12.9%) patients carried two or more variants in different CPS genes. Seventy of 198 (35.4%) patients fulfilled the Jongmans' and/or MIPOGG criteria indicating an underlying CPS, including two of the 9 (22.2%) patients with an adult-onset CPS versus 18 of the 21 (85.7%) patients with a childhood-onset CPS (p = 0.0022), eight of the additional 23 (34.8%) patients with a heterozygous PV associated with biallelic CPS, and 42 patients without PVs. Children with a central nervous system (CNS) tumor had family members with CNS tumors more frequently than patients with other cancers (11/44, p = 0.04), but 42 of 44 (95.5%) cases did not have a PV in a CPS gene.

CONCLUSION: These results demonstrate the value of systematically screening pediatric cancer patients for CPSs and indicate that a higher proportion of childhood cancers may be linked to predisposing germline variants than previously supposed.

OriginalsprogEngelsk
Artikelnummere1009231
TidsskriftPlos Genetics
Vol/bind16
Udgave nummer12
Sider (fra-til)e1009231
ISSN1553-7404
DOI
StatusUdgivet - 17 dec. 2020

ID: 61712717